Bone Marrow Transplantation - Table of Contents alert Volume 50 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 50, Issue 2 (February 2015) In this issue Editorial Comment Review Special Report Original Articles Letters to the Editor Erratum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top Can determination of gene polymorphism be of practical value in tailoring the treatment of HSCT patients? A Lange and E Jaskula Bone Marrow Transplant 2015 50: 161-162; 10.1038/bmt.2014.295 Full Text Comment Top Measureable residual disease (MRD): much ado about nothing? R P Gale Bone Marrow Transplant 2015 50: 163-164; advance online publication, October 27, 2014; 10.1038/bmt.2014.239 Full Text Review Top Optimizing drug therapy in pediatric SCT: Focus on pharmacokinetics J S McCune, P Jacobson, A Wiseman and O Militano Bone Marrow Transplant 2015 50: 165-172; advance online publication, October 27, 2014; 10.1038/bmt.2014.235 Abstract | Full Text Special Report Top SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking OPEN T Alexander, A Bondanza, P A Muraro, R Greco, R Saccardi, T Daikeler, M Kazmi, C Hawkey, B P Simoes, K Leblanc, W E Fibbe, J Moore, E Snarski, T Martin, F Hiepe, A Velardi, A Toubert, J A Snowden and D Farge on behalf of the EBMT Autoimmune Diseases Working Party (ADWP) and Immunobiology Working Party (IWP) Bone Marrow Transplant 2015 50: 173-180; advance online publication, November 10, 2014; 10.1038/bmt.2014.251 Abstract | Full Text Original Articles Top ACUTE LEUKEMIA Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study. F Locatelli, R Masetti, R Rondelli, M Zecca, F Fagioli, A Rovelli, C Messina, E Lanino, A Bertaina, C Favre, G Giorgiani, M Ripaldi, O Ziino, G Palumbo, M Pillon, A Pession, S Rutella and A Prete on behalf of AIEOP BMT Working Group Bone Marrow Transplant 2015 50: 181-188; advance online publication, November 10, 2014; 10.1038/bmt.2014.246 Abstract | Full Text CHRONIC LEUKEMIA Clinical and biological predictors of outcome following relapse of CML post-allo-SCT N A Jain, S Ito, X Tian, R Kurlander, M Battiwalla, K Lu, B N Savani, V Malkovska, K Rezvani, R Q Le, A Shenoy, C S Hourigan, K Keyvanfar, E Koklanaris, J Superata, P Muranski, A J Barrett and A S M Yong Bone Marrow Transplant 2015 50: 189-196; advance online publication, November 10, 2014; 10.1038/bmt.2014.249 Abstract | Full Text LYMPHOMA Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor V Bachanova, L J Burns, T Wang, J Carreras, R P Gale, P H Wiernik, K K Ballen, B Wirk, R Munker, D A Rizzieri, Y-B Chen, J Gibson, G Akpek, L J Costa, R T Kamble, M D Aljurf, J W Hsu, M S Cairo, H C Schouten, U Bacher, B N Savani, J R Wingard, H M Lazarus, G G Laport, S Montoto, D G Maloney, S M Smith, C Brunstein and W Saber Bone Marrow Transplant 2015 50: 197-203; advance online publication, November 17, 2014; 10.1038/bmt.2014.259 Abstract | Full Text PLASMA CELL DISORDERS Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents V H Jimenez-Zepeda, D E Reece, S Trudel, C Chen, R Tiedemann and V Kukreti Bone Marrow Transplant 2015 50: 204-208; advance online publication, October 27, 2014; 10.1038/bmt.2014.237 Abstract | Full Text Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years H W Auner, R Szydlo, J Hoek, H Goldschmidt, A M Stoppa, G J Morgan, P Moreau, M Attal, G Marit, N Russell, M Brune, G Cook, P Sonneveld, S Schönland, L Garderet and N Kröger on behalf of the Plasma Cell Disorders Subcommittee of the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancies Working Party Bone Marrow Transplant 2015 50: 209-215; advance online publication, November 10, 2014; 10.1038/bmt.2014.255 Abstract | Full Text AUTOIMMUNE DISORDERS Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP) E Snarski, J A Snowden, M C Oliveira, B Simoes, M Badoglio, K Carlson, J Burman, J Moore, M Rovira, R E Clark, A Saiz, S Hadj-Khelifa, J Tan, A Crescimanno, M Musso, T Martin and D Farge Bone Marrow Transplant 2015 50: 216-220; advance online publication, November 10, 2014; 10.1038/bmt.2014.248 Abstract | Full Text SOLID CANCERS High-dose chemotherapy for high-risk retinoblastoma: clinical course and outcome of 14 cases in the National Cancer Center, Japan N Yasui, H Kawamoto, M Fujiwara, Y Aihara, C Ogawa, A Hosono and S Suzuki Bone Marrow Transplant 2015 50: 221-224; advance online publication, December 1, 2014; 10.1038/bmt.2014.256 Abstract | Full Text GRAFT MANIPULATION Refinement of treatment strategies in ex vivo T-cell-depleted haploidentical SCT for pediatric patients H J Im, K N Koh, J K Suh, S W Lee, E S Choi, S Jang, S W Kwon, C-J Park and J J Seo Bone Marrow Transplant 2015 50: 225-231; advance online publication, October 13, 2014; 10.1038/bmt.2014.232 Abstract | Full Text HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study K Gagne, P Loiseau, V Dubois, F Dufossé, P Perrier, A Dormoy, I Jollet, V Renac, D Masson, C Picard, X Lafarge, D Hanau, F Quainon, F Delbos, B Coeffic, Léna Absi, J-F Eliaou, V Moalic, M Fort, M de Matteis, I Theodorou, F Hau, A Batho, B Pedron, S Caillat-Zucman, E Marry, N Raus, I Yakoub-Agha and A Cesbron on behalf of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) Bone Marrow Transplant 2015 50: 232-236; advance online publication, November 3, 2014; 10.1038/bmt.2014.253 Abstract | Full Text Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation B E Shaw, F Lee, S Krishnamurthy, J L Byrne, C Seedhouse, N P Mayor, H Maldonado-Torres, A Saudemont, S G E Marsh, J A Madrigal and N H Russell Bone Marrow Transplant 2015 50: 237-243; advance online publication, October 27, 2014; 10.1038/bmt.2014.238 Abstract | Full Text SUPPORTIVE CARE The impact of improved JACIE standards on the care of related BM and PBSC donors C Anthias, M E Ethell, M N Potter, A Madrigal and B E Shaw Bone Marrow Transplant 2015 50: 244-247; advance online publication, November 10, 2014; 10.1038/bmt.2014.260 Abstract | Full Text TRANSPLANT TOXICITIES Successful early unmanipulated haploidentical transplantation with reduced-intensity conditioning for primary graft failure after cord blood transplantation in hematologic malignancy patients B L Tang, X Y Zhu, C C Zheng, H L Liu, L Q Geng, X B Wang, K Y Ding, W Yao, J Tong, K D Song, L Zhang, P Qiang and Z M Sun Bone Marrow Transplant 2015 50: 248-252; advance online publication, November 3, 2014; 10.1038/bmt.2014.250 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) M Y Detrait, S Morisset, R Peffault de Latour, I Yakoub-Agha, R Crocchiolo, R Tabrizi, J-O Bay, P Chevalier, F Barraco, N Raus, S Vigouroux, L Magro, M Mohty, N Milpied, D Blaise, G Socié and M Michallet Bone Marrow Transplant 2015 50: 253-258; advance online publication, November 3, 2014; 10.1038/bmt.2014.244 Abstract | Full Text IMMUNE RECOVERY Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia N Jacque, S Nguyen, J-L Golmard, M Uzunov, A Garnier, V Leblond, J-P Vernant, D Bories and N Dhédin Bone Marrow Transplant 2015 50: 259-265; advance online publication, November 10, 2014; 10.1038/bmt.2014.254 Abstract | Full Text Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation M C Elze, O Ciocarlie, A Heinze, S Kloess, T Gardlowski, R Esser, T Klingebiel, P Bader, S Huenecke, M Serban, U Köhl and J L Hutton Bone Marrow Transplant 2015 50: 266-273; advance online publication, November 10, 2014; 10.1038/bmt.2014.257 Abstract | Full Text INFECTIONS Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time R Parody, R Martino, R de la Cámara, A García-Noblejas, A Esquirol, I Garcia-Cadenas, T Villaescusa, D Caballero, M Rovira, F Fernandez-Avilés, F J Marquez-Malaver, I Espigado, C Castilla-Llorente, I Heras, M A Cabero, J R Cabrera, P Barba, D Valcarcel, I Sánchez-Ortega, R F Duarte, D Serrano, F Carretero and L Vazquez for the Infectious/Non-infectious Complications Subcommittees of the Grupo Español de Trasplante Hematopoyético (GETH) Bone Marrow Transplant 2015 50: 274-281; advance online publication, October 27, 2014; 10.1038/bmt.2014.229 Abstract | Full Text Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy C Girmenia, G M Rossolini, A Piciocchi, A Bertaina, G Pisapia, D Pastore, S Sica, A Severino, L Cudillo, F Ciceri, R Scimè, L Lombardini, C Viscoli, A Rambaldi and the Gruppo Italiano Trapianto Midollo Osseo (GITMO) Bone Marrow Transplant 2015 50: 282-288; advance online publication, October 13, 2014; 10.1038/bmt.2014.231 Abstract | Full Text QOL AND PATIENTS' CARE Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT E N Amin, G S Phillips, P Elder, S Jaglowski, S M Devine and K L Wood Bone Marrow Transplant 2015 50: 289-295; advance online publication, November 24, 2014; 10.1038/bmt.2014.264 Abstract | Full Text Letters to the Editor Top Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome T Nishihori, R Komrokji, K Shain and C Anasetti Bone Marrow Transplant 2015 50: 296-297; advance online publication, October 20, 2014; 10.1038/bmt.2014.233 Full Text Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT A Bosch-Vizcaya, R Rodriguez-Romanos, J B Nieto, R de la Cámara, S Brunet, C Vallejo, G Osca-Gelis, C Martínez-Laperche, I Buño, Á Urbano-Ispizúa, M González, A Jiménez-Velasco and D Gallardo on behalf of the GvHD/Immunotherapy committee of the Spanish Group for Hematopoietic Transplant (GETH) Bone Marrow Transplant 2015 50: 298-300; advance online publication, October 20, 2014; 10.1038/bmt.2014.234 Full Text Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma H Ariizumi, B Saito, Y Uto, N Hattori, H Nakashima, K Yanagisawa, H Harada, H Mori and T Nakamaki Bone Marrow Transplant 2015 50: 301-303; advance online publication, October 27, 2014; 10.1038/bmt.2014.236 Full Text Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation A C Mamez, L Souchet, D Roos-Weil, M Uzunov, A L Brun, C Algrin, V Leblond and S Nguyen Bone Marrow Transplant 2015 50: 304-306; advance online publication, November 3, 2014; 10.1038/bmt.2014.243 Full Text Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus H Ali, J Palmer, Z Eroglu, T Stiller, S H Thomas, S Khaled, S Shayani, P Parker, S J Forman and R Nakamura Bone Marrow Transplant 2015 50: 307-309; advance online publication, November 3, 2014; 10.1038/bmt.2014.245 Full Text Safety of stem cell mobilization in donors with sickle cell trait M Al-Khabori, F Al-Ghafri, S Al-Kindi, A Z Al-Riyami, K Al-Farsi, M Al-Huneini, D Dennison, A Al-Rawas, H Khan and S Daar Bone Marrow Transplant 2015 50: 310-311; advance online publication, November 3, 2014; 10.1038/bmt.2014.252 Full Text Monitoring mycophenolate mofetil is necessary for the effective prophylaxis of acute GVHD after cord blood transplantation Y Arai, T Kondo, T Kitano, M Hishizawa, K Yamashita, N Kadowaki, T Yamamoto, I Yano, K Matsubara and A Takaori-Kondo Bone Marrow Transplant 2015 50: 312-314; advance online publication, November 10, 2014; 10.1038/bmt.2014.258 Full Text Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation S-K Tey, M P Davenport, G R Hill, G A Kennedy, S T Durrant, R Khanna and D Cromer Bone Marrow Transplant 2015 50: 315-316; advance online publication, November 17, 2014; 10.1038/bmt.2014.265 Full Text B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY A Roberto, L Castagna, S Gandolfi, V Zanon, S Bramanti, B Sarina, R Crocchiolo, E Todisco, C Carlo-Stella, P Tentorio, I Timofeeva, A Santoro, S Della Bella, M Roederer, D Mavilio and E Lugli Bone Marrow Transplant 2015 50: 317-319; advance online publication, November 24, 2014; 10.1038/bmt.2014.266 Full Text Erratum Top Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the AIEOP AML-2002/01 study F Locatelli, R Masetti, R Rondelli, M Zecca, F Fagioli, A Rovelli, C Messina, E Lanino, A Bertaina, C Favre, G Giorgiani, M Ripaldi, O Ziino, G Palumbo, M Pillon, A Pession, S Rutella and A Prete on behalf of AIEOP BMT Working Group Bone Marrow Transplant 2015 50: 320; 10.1038/bmt.2014.291 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.